Clinical trial
Ezetimibe Utilization Early After Acute Myocardial Infarction. "EzAMI Trial"
NCT04701242 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ezetimibe Utilization Early After Acute Myocardial Infarction. "EzAMI Trial"
- Lead sponsor
- Cairo University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 24, 2021
- Completion date
- December 31, 2025
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction, dyslipidemias